Global Pain Management Drugs Market Growth (Status and Outlook) 2023-2029

Global Pain Management Drugs Market Growth (Status and Outlook) 2023-2029

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

LPI (LP Information)' newest research report, the “Pain Management Drugs Industry Forecast” looks at past sales and reviews total world Pain Management Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Management Drugs sales for 2023 through 2029. With Pain Management Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pain Management Drugs industry.

This Insight Report provides a comprehensive analysis of the global Pain Management Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pain Management Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pain Management Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pain Management Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pain Management Drugs.

The global Pain Management Drugs market size is projected to grow from US$ 34590 million in 2022 to US$ 43780 million in 2029; it is expected to grow at a CAGR of 3.4% from 2023 to 2029.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

This report presents a comprehensive overview, market shares, and growth opportunities of Pain Management Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Generic Opioids
Branded Opioids
NSAIDs
Others

Segmentation by application
Hospitals
Drugstores
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan

Please note: The report will take approximately 2 business days to prepare and deliver.